MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,259,000 | -33.9% | 400,610 | -19.1% | 0.26% | -9.4% |
| Q3 2015 | $18,548,000 | -13.6% | 494,890 | -21.7% | 0.29% | -9.5% |
| Q2 2015 | $21,472,000 | -24.9% | 631,715 | -21.8% | 0.32% | -19.7% |
| Q1 2015 | $28,604,000 | -15.3% | 808,009 | -18.5% | 0.40% | -17.9% |
| Q4 2014 | $33,785,000 | -18.9% | 991,932 | -8.2% | 0.48% | -17.5% |
| Q3 2014 | $41,676,000 | +3.8% | 1,080,534 | +4.7% | 0.58% | +9.6% |
| Q2 2014 | $40,165,000 | +58.8% | 1,031,978 | +39.5% | 0.53% | +94.2% |
| Q1 2014 | $25,286,000 | -18.8% | 739,575 | -50.2% | 0.27% | -18.9% |
| Q4 2013 | $31,154,000 | – | 1,484,930 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |